Cargando…

A random priming amplification method for whole genome sequencing of SARS-CoV-2 virus

BACKGROUND: Non-targeted whole genome sequencing is a powerful tool to comprehensively identify constituents of microbial communities in a sample. There is no need to direct the analysis to any identification before sequencing which can decrease the introduction of bias and false negatives results....

Descripción completa

Detalles Bibliográficos
Autores principales: Chrzastek, Klaudia, Tennakoon, Chandana, Bialy, Dagmara, Freimanis, Graham, Flannery, John, Shelton, Holly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148844/
https://www.ncbi.nlm.nih.gov/pubmed/35644636
http://dx.doi.org/10.1186/s12864-022-08563-z
_version_ 1784717095841300480
author Chrzastek, Klaudia
Tennakoon, Chandana
Bialy, Dagmara
Freimanis, Graham
Flannery, John
Shelton, Holly
author_facet Chrzastek, Klaudia
Tennakoon, Chandana
Bialy, Dagmara
Freimanis, Graham
Flannery, John
Shelton, Holly
author_sort Chrzastek, Klaudia
collection PubMed
description BACKGROUND: Non-targeted whole genome sequencing is a powerful tool to comprehensively identify constituents of microbial communities in a sample. There is no need to direct the analysis to any identification before sequencing which can decrease the introduction of bias and false negatives results. It also allows the assessment of genetic aberrations in the genome (e.g., single nucleotide variants, deletions, insertions and copy number variants) including in noncoding protein regions. METHODS: The performance of four different random priming amplification methods to recover RNA viral genetic material of SARS-CoV-2 were compared in this study. In method 1 (H-P) the reverse transcriptase (RT) step was performed with random hexamers whereas in methods 2–4 RT incorporating an octamer primer with a known tag. In methods 1 and 2 (K-P) sequencing was applied on material derived from the RT-PCR step, whereas in methods 3 (SISPA) and 4 (S-P) an additional amplification was incorporated before sequencing. RESULTS: The SISPA method was the most effective and efficient method for non-targeted/random priming whole genome sequencing of SARS-CoV-2 that we tested. The SISPA method described in this study allowed for whole genome assembly of SARS-CoV-2 and influenza A(H1N1)pdm09 in mixed samples. We determined the limit of detection and characterization of SARS-CoV-2 virus which was 10(3) pfu/ml (Ct, 22.4) for whole genome assembly and 10(1) pfu/ml (Ct, 30) for metagenomics detection. CONCLUSIONS: The SISPA method is predominantly useful for obtaining genome sequences from RNA viruses or investigating complex clinical samples as no prior sequence information is needed. It might be applied to monitor genomic virus changes, virus evolution and can be used for fast metagenomics detection or to assess the general picture of different pathogens within the sample. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12864-022-08563-z.
format Online
Article
Text
id pubmed-9148844
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-91488442022-05-31 A random priming amplification method for whole genome sequencing of SARS-CoV-2 virus Chrzastek, Klaudia Tennakoon, Chandana Bialy, Dagmara Freimanis, Graham Flannery, John Shelton, Holly BMC Genomics Research BACKGROUND: Non-targeted whole genome sequencing is a powerful tool to comprehensively identify constituents of microbial communities in a sample. There is no need to direct the analysis to any identification before sequencing which can decrease the introduction of bias and false negatives results. It also allows the assessment of genetic aberrations in the genome (e.g., single nucleotide variants, deletions, insertions and copy number variants) including in noncoding protein regions. METHODS: The performance of four different random priming amplification methods to recover RNA viral genetic material of SARS-CoV-2 were compared in this study. In method 1 (H-P) the reverse transcriptase (RT) step was performed with random hexamers whereas in methods 2–4 RT incorporating an octamer primer with a known tag. In methods 1 and 2 (K-P) sequencing was applied on material derived from the RT-PCR step, whereas in methods 3 (SISPA) and 4 (S-P) an additional amplification was incorporated before sequencing. RESULTS: The SISPA method was the most effective and efficient method for non-targeted/random priming whole genome sequencing of SARS-CoV-2 that we tested. The SISPA method described in this study allowed for whole genome assembly of SARS-CoV-2 and influenza A(H1N1)pdm09 in mixed samples. We determined the limit of detection and characterization of SARS-CoV-2 virus which was 10(3) pfu/ml (Ct, 22.4) for whole genome assembly and 10(1) pfu/ml (Ct, 30) for metagenomics detection. CONCLUSIONS: The SISPA method is predominantly useful for obtaining genome sequences from RNA viruses or investigating complex clinical samples as no prior sequence information is needed. It might be applied to monitor genomic virus changes, virus evolution and can be used for fast metagenomics detection or to assess the general picture of different pathogens within the sample. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12864-022-08563-z. BioMed Central 2022-05-30 /pmc/articles/PMC9148844/ /pubmed/35644636 http://dx.doi.org/10.1186/s12864-022-08563-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Chrzastek, Klaudia
Tennakoon, Chandana
Bialy, Dagmara
Freimanis, Graham
Flannery, John
Shelton, Holly
A random priming amplification method for whole genome sequencing of SARS-CoV-2 virus
title A random priming amplification method for whole genome sequencing of SARS-CoV-2 virus
title_full A random priming amplification method for whole genome sequencing of SARS-CoV-2 virus
title_fullStr A random priming amplification method for whole genome sequencing of SARS-CoV-2 virus
title_full_unstemmed A random priming amplification method for whole genome sequencing of SARS-CoV-2 virus
title_short A random priming amplification method for whole genome sequencing of SARS-CoV-2 virus
title_sort random priming amplification method for whole genome sequencing of sars-cov-2 virus
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148844/
https://www.ncbi.nlm.nih.gov/pubmed/35644636
http://dx.doi.org/10.1186/s12864-022-08563-z
work_keys_str_mv AT chrzastekklaudia arandomprimingamplificationmethodforwholegenomesequencingofsarscov2virus
AT tennakoonchandana arandomprimingamplificationmethodforwholegenomesequencingofsarscov2virus
AT bialydagmara arandomprimingamplificationmethodforwholegenomesequencingofsarscov2virus
AT freimanisgraham arandomprimingamplificationmethodforwholegenomesequencingofsarscov2virus
AT flanneryjohn arandomprimingamplificationmethodforwholegenomesequencingofsarscov2virus
AT sheltonholly arandomprimingamplificationmethodforwholegenomesequencingofsarscov2virus
AT chrzastekklaudia randomprimingamplificationmethodforwholegenomesequencingofsarscov2virus
AT tennakoonchandana randomprimingamplificationmethodforwholegenomesequencingofsarscov2virus
AT bialydagmara randomprimingamplificationmethodforwholegenomesequencingofsarscov2virus
AT freimanisgraham randomprimingamplificationmethodforwholegenomesequencingofsarscov2virus
AT flanneryjohn randomprimingamplificationmethodforwholegenomesequencingofsarscov2virus
AT sheltonholly randomprimingamplificationmethodforwholegenomesequencingofsarscov2virus